Islet assessment for transplantation

Current Opinion in Organ Transplantation

Volumn 14, Issue 6, 2009, Pages 674-682

  Papas, Klearchos K ^a,b   Suszynski, Thomas M ^a   Colton, Clark K ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Marginal mass; Oxygen consumption rate; Potency; Purity; Release criteria; Viability

Indexed keywords

7 AMINODACTINOMYCIN; ACRIDINE ORANGE; CALCEIN; DITHIZONE; DNA; ENDOTOXIN; ETHIDIUM BROMIDE; FLUORESCEIN DIACETATE; GLUCOSE; INSULIN; OXYGEN; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE; TETRAZOLIUM;

BIOASSAY; CELL DAMAGE; CELL DEATH; CELL MEMBRANE; CELL VIABILITY; CORRELATION ANALYSIS; DIABETES MELLITUS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FLUOROMETRY; FOOD AND DRUG ADMINISTRATION; IN VIVO STUDY; INSULIN RELEASE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; NUDE MOUSE; OXYGEN CONSUMPTION; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; QUANTITATIVE ASSAY; REVIEW;

ANIMALS; BIOLOGICAL ASSAY; CELL SURVIVAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; OXYGEN CONSUMPTION; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TISSUE AND ORGAN HARVESTING; TREATMENT OUTCOME;

EID: 74349099562     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328332a489     Document Type: Review

References (63)

1. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355:1318-1330.
2. Bellin MD, Kandaswamy R, Parkey J, et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 2008; 8:2463-2470.
3. Benhamou PY,Milliat-Guittard L, Wojtusciszyn A, et al. Quality of life after islet transplantation: Data from the GRAGIL 1 and 2 trials. Diabet Med 2009; 26:617-621.
4. Hogan A, Pileggi A, Ricordi C. Transplantation: Current developments and future directions; the future of clinical islet transplantation as a cure for diabetes. Front Biosci 2008; 13:1192-1205.
5. Keymeulen B, Gillard P, Mathieu C, et al. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci USA 2006; 103:17444-17449.
6. Leitao CB, Tharavanij T, Cure P, et al. Restoration of hypoglycemia awareness after islet transplantation. Diabetes Care 2008; 31:2113-2115.
7. Ricordi C, Hering BJ, Shapiro AM. Beta-cell transplantation for diabetes therapy. Lancet 2008; 372:27-28; author reply 29-30.
8. Tharavanij T, Betancourt A, Messinger S, et al. Improved long-term healthrelated quality of life after islet transplantation. Transplantation 2008; 86: 1161-1167.
9. Clinical Islet Transplantation Consortium (official website). http://www. citisletstudy.org/. [Accessed 7 August 2009].
10. Weber DJ. FDA regulation of allogeneic islets as a biological product. Cell Biochem Biophys 2004; 40 (3 Suppl):19-22.
11. Barnett MJ, McGhee-Wilson D, Shapiro AM, Lakey JR. Variation in human islet viability based on different membrane integrity stains. Cell Transplant 2004; 13:481-488.
12. Gerling IC, Kotb M, Fraga D, et al. No correlation between in vitro and in vivo function of human islets. Transplant Proc 1998; 30:587-588.
13. Ricordi C, Lakey JR, Hering BJ. Challenges toward standardization of islet isolation technology. Transplant Proc 2001; 33:1709.
14. Bertuzzi F, Ricordi C. Prediction of clinical outcome in islet allotransplantation. Diabetes Care 2007; 30:410-417.
15. Ricordi C.Quantitative and qualitative standards for islet isolation assessment in humans and large mammals. Pancreas 1991; 6:242-244.
16. Colton CK, Papas KK, Pisania A, et al. Characterizations of islet preparations. In: Halberstadt C, Emerich DF, editors. Cellular transplantation: From laboratory to clinic; 2007. pp. 85-134.
17. Fernandez LA, Hatch EW, Armann B, et al. Validation of large particle flow cytometry for the analysis and sorting of intact pancreatic islets. Transplantation 2005; 80:729-737.
18. Pisania A, Papas K, Powers DE, et al. Enumeration of islets by nuclei counting and light microscopic analysis. Lab Invest (in press).
19. Ichii H, Inverardi L, Pileggi A, et al. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 2005; 5:1635-1645.
20. Pisania A, Weir GC, O'Neil JJ, et al. Quantitative analysis of cell composition and purity of human pancreatic islet preparations. Lab Invest (in press).
21. Street CN, Lakey JR, Shapiro AM, et al. Islet graft assessment in the Edmonton protocol: Implications for predicting long-term clinical outcomes. Diabetes 2004; 53:3107-3114.
22. Dionne KE, Colton CK, Yarmush ML. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 1993; 42:12-21.
23. London NJ, Thirdborough SM, Swift SM, et al. The diabetic 'human reconstituted' severe combined immunodeficient (SCID-hu) mouse: A model for isogeneic, allogeneic, and xenogeneic human islet transplantation. Transplant Proc 1991; 23 (1 Pt 1):749.
24. Ricordi C, Scharp DW, Lacy PE. Reversal of diabetes in nude mice after transplantation of fresh and 7-day-cultured (24 degrees C) human pancreatic islets. Transplantation 1988; 45:994-996.
25. Armann B, Hanson MS, Hatch E, et al. Quantification of basal and stimulated ROS levels as predictors of islet potency and function. Am J Transplant 2007; 7:38-47.
26. Fraker C, TimminsMR, Guarino RD, et al. The use of the BD oxygen biosensor system to assess isolated human islets of langerhans: oxygen consumption as a potential measure of islet potency. Cell Transplant 2006; 15:745-758.
27. Goto M, Abe H, Ito-Sasaki T, et al. A novel predictive method for assessing the quality of isolated pancreatic islets using scanning electrochemical microscopy. Transplant Proc 2009; 41:311-313.
28. Goto M, Holgersson J, Kumagai-Braesch M, Korsgren O. The ADP/ATP ratio: A novel predictive assay for quality assessment of isolated pancreatic islets. Am J Transplant 2006; 6:2483-2487.
29. Hanson MS, Steffen A, Danobeitia JS, et al. Flow cytometric quantification of glucose-stimulated beta-cell metabolic flux can reveal impaired islet functional potency. Cell Transplant 2008; 17:1337-1347.
30. Kim JH, Park SG, Lee HN, et al. ATP measurement predicts porcine islet transplantation outcome in nude mice. Transplantation 2009; 87:166-169.
31. Mohammed JS, Wang Y, Harvat TA, et al. Microfluidic device for multimodal characterization of pancreatic islets. Lab Chip 2009; 9:97-106.
32. Papas KK, Colton CK, Nelson RA, et al. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant 2007; 7:707-713.
33. Papas KK, Pisania A, Wu H, et al. A stirred microchamber for oxygen consumption rate measurements with pancreatic islets. Biotechnol Bioeng 2007; 98:1071-1082. (Pubitemid 350205583)
34. Sweet IR, Gilbert M, Scott S, et al. Glucose-stimulated increment in oxygen consumption rate as a standardized test of human islet quality. Am J Transplant 2008; 8:183-192.
35. Yamamoto T, Horiguchi A, Ito M, et al. Quality control for clinical islet transplantation: organ procurement and preservation, the islet processing facility, isolation, and potency tests. J Hepatobiliary Pancreat Surg 2009; 16:131-136.
36. Koulmanda M, Papas KK, Qipo A, et al. Islet oxygen consumption rate as a predictor of in vivo efficacy posttransplantation. Xenotransplantation 2003; 10:484.
37. Gray DW. The role of exocrine tissue in pancreatic islet transplantation. Transplant Int 1989; 2:41-45.
38. Hesse UJ, Sutherland DE, Gores PF, et al. Comparison of splenic and renal subcapsular islet autografting in dogs. Transplantation 1986; 41:271-274.
39. Gray DW, Morris PJ. Developments in isolated pancreatic islet transplantation. Transplantation 1987; 43:321-331.
40. Caiazzo R, Gmyr V, Kremer B, et al. Quantitative in vivo islet potency assay in normoglycemic nude mice correlates with primary graft function after clinical transplantation. Transplantation 2008; 86:360-363.
41. Yonekawa Y, Okitsu T, Wake K, et al. A new mouse model for intraportal islet transplantation with limited hepatic lobe as a graft site. Transplantation 2006; 82:712-715.
42. Suszynski TM, Wildey GM, Falde EJ, et al. The ATP/DNA ratio is a better indicator of islet cell viability than the ADP/ATP ratio. Transplant Proc 2008; 40:346-350.
43. Thomas F, WuJ, Contreras JL, et al. A tripartite anoikis-like mechanism causes early isolated islet apoptosis. Surgery 2001; 130:333-338.
44. Cattan P, Berney T, Schena S, et al. Early assessment of apoptosis in isolated islets of Langerhans. Transplantation 2001; 71:857-862. (Pubitemid 32417343)
45. Pipeleers DG, Pipeleers-Marichal M, Hannaert JC, et al. Transplantation of purified islet cells in diabetic rats. I. Standardization of islet cell grafts. Diabetes 1991; 40:908-919.
46. Pipeleers DG, Pipeleers-Marichal MA. A method for the purification of single A, B and D cells and for the isolation of coupled cells from isolated rat islets. Diabetologia 1981; 20:654-663.
47. Weir GC, Halban PA, Meda P, et al. Dispersed adult rat pancreatic islet cells in culture: A, B, and D cell function. Metabolism 1984; 33:447-453.
48. Papas KK, Constantinidis I, Sambanis A. Cultivation of recombinant, insulinsecreting AtT-20 cells as free and entrapped spheroids. Cytotechnology 1993; 13:1-12.
49. Pisania A. Development of quantitative methods for quality assessment of islets of Langerhans. Cambridge, Massachusetts, USA: Massachusetts Institute of Technology; 2007.
50. Stubenitsky BM, Booster MM, Brasile L, et al. II: Ex vivo viability testing of kidneys after postmortem warm ischemia. ASAIO J 2000; 46:62-64.
51. Yang H, Jia XM, Acker JP, et al. Routine assessment of viability in splitthickness skin. J Burn Care Rehabil 2000; 21:99-104.
52. Zhang Y, Ohkohchi N, Oikawa K, et al. Assessment of viability of the liver graft in different cardiac arrest models. Transplant Proc 2000; 32:2345-2347.
53. Ricciardi R, Foley DP, Quarfordt SH, et al. Hemodynamic and metabolic variables predict porcine ex vivo liver function. J Surg Res 2001; 96:114-119.
54. Schwitalla S, Heres F, Rohl FW, et al. Intraoperative oxygen consumption and organ function in liver transplantation (in German). Anaesthesiol Reanim 2001; 26:88-94.
55. Martin J, Yerebakan C, Goebel H, et al. Viability of the myocardium after twenty-four-hour heart conservation: A preliminary study. Thorac Cardiovasc Surg 2003; 51:196-203.
56. Sweet IR, Gilbert M. Contribution of calcium influx in mediating glucose-stimulated oxygen consumption in pancreatic islets. Diabetes 2006; 55:3509-3519.
57. Papas KK, Colton CK, Qipo A, et al. Prediction of marginal mass required for successful islet transplantation. J Invest Surg (in press).
58. Wang W, Upshaw L, Strong DM, et al. Increased oxygen consumption rates in response to high glucose detected by a novel oxygen biosensor system in nonhuman primate and human islets. J Endocrinol 2005; 185:445-455.
59. Papas KK, Long RC Jr, Sambanis A, Constantinidis I. Development of a bioartificial pancreas: I. Long-termpropagation and basal and induced secretion fromentrapped betaTC3 cell cultures. Biotechnol Bioeng 1999; 66:219-230.
60. Papas KK, Long RC Jr, Sambanis A, Constantinidis I. Development of a bioartificial pancreas: II. Effects of oxygen on long-term entrapped betaTC3 cell cultures. Biotechnol Bioeng 1999; 66:231-237.
61. Mukundan NE, Flanders PC, Constantinidis I, et al. Oxygen consumption rates of free and alginate-entrapped beta TC3 mouse insulinoma cells. Biochem Biophys Res Commun 1995; 210:113-118.
62. Low CA. Transient oxygen consumption rate measurements with the BD Oxygen Biosensor System. Cambridge, Massachusetts, USA: Massachusetts Institute of Technology; 2008.
63. Migliavacca B, Nano R, Antonioli B, et al. Identification of in vitro parameters predictive of graft function: A study in an animal model of islet transplantation. Transplant Proc 2004; 36:612-613.